Literature DB >> 21435327

Escherichia coli and Staphylococcus aureus: bad news and good news from the European Antimicrobial Resistance Surveillance Network (EARS-Net, formerly EARSS), 2002 to 2009.

C Gagliotti1, A Balode, F Baquero, J Degener, H Grundmann, D Gür, V Jarlier, G Kahlmeter, J Monen, D L Monnet, G M Rossolini, C Suetens, K Weist, O Heuer.   

Abstract

Based on data collected by the European Antimicrobial Resistance Surveillance Network (EARS-Net) and the former EARSS, the present study describes the trends in antimicrobial susceptibility patterns and occurrence of invasive infections caused by Escherichia coli and Staphylococcus aureus in the period from 2002 to 2009. Antimicrobial susceptibility results from 198 laboratories in 22 European countries reporting continuously on these two microorganisms during the entire study period were included in the analysis. The number of bloodstream infections caused by E. coli increased remarkably by 71% during the study period, while bloodstream infections caused by S. aureus increased by 34%. At the same time, an alarming increase of antimicrobial resistance in E. coli was observed, whereas for S. aureus the proportion of meticillin resistant isolates decreased. The observed trend suggests an increasing burden of disease caused by E. coli. The reduction in the proportion of meticillin-resistant S. aureus and the lesser increase in S. aureus infections, compared with E. coli, may reflect the success of infection control measures at hospital level in several European countries.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21435327     DOI: 10.2807/ese.16.11.19819-en

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  48 in total

1.  Escherichia coli early-onset sepsis: trends over two decades.

Authors:  Natalia Mendoza-Palomar; Milena Balasch-Carulla; Sabina González-Di Lauro; Maria Concepció Céspedes; Antònia Andreu; Marie Antoinette Frick; Maria Ángeles Linde; Pere Soler-Palacin
Journal:  Eur J Pediatr       Date:  2017-08-02       Impact factor: 3.183

2.  Genotyping of 353 Staphylococcus aureus bloodstream isolates collected between 2004 and 2009 at a Norwegian university hospital and potential associations with clinical parameters.

Authors:  Hege Vangstein Aamot; Anita Blomfeldt; Arne N Eskesen
Journal:  J Clin Microbiol       Date:  2012-07-11       Impact factor: 5.948

3.  Molecular characterization of methicillin-sensitive Staphylococcus aureus isolates from bacteremic patients in a Norwegian University Hospital.

Authors:  Anita Blomfeldt; Hege Vangstein Aamot; Arne N Eskesen; Fredrik Müller; Stefan Monecke
Journal:  J Clin Microbiol       Date:  2012-11-07       Impact factor: 5.948

4.  Varying fitness cost associated with resistance to fluoroquinolones governs clonal dynamic of methicillin-resistant Staphylococcus aureus.

Authors:  A Horváth; O Dobay; S Kardos; Á Ghidán; Á Tóth; J Pászti; E Ungvári; P Horváth; K Nagy; S Zissman; M Füzi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-01-05       Impact factor: 3.267

5.  Incidence and antimicrobial resistance trends in bloodstream infections caused by ESKAPE and Escherichia coli at a large teaching hospital in Rome, a 9-year analysis (2007-2015).

Authors:  Giulia De Angelis; Barbara Fiori; Giulia Menchinelli; Tiziana D'Inzeo; Flora Marzia Liotti; Grazia Angela Morandotti; Maurizio Sanguinetti; Brunella Posteraro; Teresa Spanu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-06-09       Impact factor: 3.267

6.  Discovery of a novel class of boron-based antibacterials with activity against gram-negative bacteria.

Authors:  Vincent Hernandez; Thibaut Crépin; Andrés Palencia; Stephen Cusack; Tsutomu Akama; Stephen J Baker; Wei Bu; Lisa Feng; Yvonne R Freund; Liang Liu; Maliwan Meewan; Manisha Mohan; Weimin Mao; Fernando L Rock; Holly Sexton; Anita Sheoran; Yanchen Zhang; Yong-Kang Zhang; Yasheen Zhou; James A Nieman; Mahipal Reddy Anugula; El Mehdi Keramane; Kingsley Savariraj; D Shekhar Reddy; Rashmi Sharma; Rajendra Subedi; Rajeshwar Singh; Ann O'Leary; Nerissa L Simon; Peter L De Marsh; Shazad Mushtaq; Marina Warner; David M Livermore; M R K Alley; Jacob J Plattner
Journal:  Antimicrob Agents Chemother       Date:  2013-01-07       Impact factor: 5.191

7.  When and how to cover for resistant gram-negative bacilli in severe sepsis and septic shock.

Authors:  Håkan Hanberger; Christian G Giske; Helen Giamarellou
Journal:  Curr Infect Dis Rep       Date:  2011-10       Impact factor: 3.725

8.  High Burden of Antimicrobial Resistance and Mortality Among Adults and Children With Community-Onset Bacterial Infections in India.

Authors:  Vidya Mave; Ajay Chandanwale; Anju Kagal; Sandhya Khadse; Dileep Kadam; Renu Bharadwaj; Vaishali Dohe; Matthew L Robinson; Aarti Kinikar; Samir Joshi; Priyanka Raichur; Katie McIntire; Savita Kanade; Jonathan Sachs; Chhaya Valvi; Usha Balasubramanian; Vandana Kulkarni; Aaron M Milstone; Ivan Marbaniang; Jonathan Zenilman; Amita Gupta
Journal:  J Infect Dis       Date:  2017-04-15       Impact factor: 5.226

Review 9.  Resistance surveillance studies: a multifaceted problem--the fluoroquinolone example.

Authors:  A Dalhoff
Journal:  Infection       Date:  2012-03-30       Impact factor: 3.553

10.  Bacteria differentially induce degradation of Bcl-xL, a survival protein, by human platelets.

Authors:  Bjoern F Kraemer; Robert A Campbell; Hansjörg Schwertz; Zechariah G Franks; Adriana Vieira de Abreu; Katharina Grundler; Benjamin T Kile; Bijaya K Dhakal; Matthew T Rondina; Walter H A Kahr; Matthew A Mulvey; Robert C Blaylock; Guy A Zimmerman; Andrew S Weyrich
Journal:  Blood       Date:  2012-10-18       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.